Easing the Disease Burden of Patients with Atopic Dermatitis

About Easing the Disease Burden of Patients with Atopic Dermatitis

Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to

Publisher

Annenberg Center for Health Sciences

Category

health & fitness

Language

en

Explicit

No

First episode

1 Nov 2021

Latest episode

1 Nov 2021

Latest episodes

5 episodes in the feed.

1. 

   1 Nov 2021

   Emerging Therapies: Phase 3 Efficacy & Safety Data

   JAK-STAT inhibitors: oral and topical JAK-STAT inhibitors vs dupilumab IL-13 antagonists IL-31 antagonists

2. 

   1 Nov 2021

   AD Therapies Approved After 2014 AAD Guidelines

   Mechanism of action, indication, efficacy, and safety Dupilumab Crisaborole

3. 

   1 Nov 2021

   Adherence to Evidence-Based Guidelines

   2014 AAD Guidelines Recommendations for topical therapies Recommendations for phototherapy

4. 

   1 Nov 2021

   Components of Basic AD Care

   Role of bathing and moisturizers Role of topical corticosteroids

5. 

   1 Nov 2021

   Unmet Needs in AD Care

   Direct and indirect effects of AD Discordance in disease burden between providers and patients Rates of inadequate disease control

Contact Easing the Disease Burden of Patients with Atopic Dermatitis

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.